Multiple myeloma laboratory tests: Difference between revisions

Jump to navigation Jump to search
Line 46: Line 46:
====Immunohistochemistry====  
====Immunohistochemistry====  
*Multiple myeolma cells are typically [[CD56]], [[CD38]], [[CD138]] positive and [[CD19]] and [[CD45]] negative.
*Multiple myeolma cells are typically [[CD56]], [[CD38]], [[CD138]] positive and [[CD19]] and [[CD45]] negative.
[[Cytogenetics]] may also be performed in myeloma for prognostic purposes.


==References==
==References==

Revision as of 17:19, 21 September 2015

Multiple myeloma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Multiple Myeloma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

Echocardiograph and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Future or Investigational Therapies

Case Studies

Case #1

Multiple myeloma laboratory tests On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Multiple myeloma laboratory tests

All Images
X-rays
Echo and Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Multiple myeloma laboratory tests

CDC on Multiple myeloma laboratory tests

Multiple myeloma laboratory tests in the news

Blogs on Multiple myeloma laboratory tests

Directions to Hospitals Treating Multiple myeloma

Risk calculators and risk factors for Multiple myeloma laboratory tests

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Laboratory findings consistent with the diagnosis of multiple myeloma include abnormal complete blood count, erythrocyte sedimentation rate (ESR), basic metabolic panel, electrophoresis and immunohistochemistry. An elevated concentration of serum protein level without concomitant elevation of serum albumin level is very suggestive of multiple myeloma.

Laboratory Findings

Complete blood count

Peripheral blood smear

  • Rouleaux formation of red blood cells.

Basic metabolic panel

Urinalysis

  • A 24-hour collection of urine is usually needed to examine the amount of protein

Electrophoresis

  • Protein electrophoresis is a method that separates proteins in the serum or urine
  • 70% of people with multiple myeloma have high levels of IgG
  • 20% of people with multiple myeloma have high levels of IgA
  • 5–10% of people with multiple myeloma produce only immunoglobulin light chains (Bence Jones proteins)
  • Rarely κ- or λ-light chains may be secreted in isolation.

Free light chain immunoassay

  • Potentially offers an improvement in monitoring disease progression and response to treatment.

Immunofixation

  • Specialized type of electrophoresis that identifies the type of M-protein or immunoglobulin light chain detected by serum or urine electrophoresis.

Quantitative immunoglobulins assay

  • Quantitative measurement of IgA, IgG, IgM immunoglobulins to detect immune paresis
  • Monoclonal gammopathy (IgA and/or IgG peak)
  • Reverse albumin:globulin ratio (low albumin, high globulin)
  • Elevated β2-microglobulin level

Immunohistochemistry

References


Template:WikiDoc Sources